Thomas Brown, MD, MBA is Chief Medical Officer of Sygnomics, a startup applying systems biology & AI to help oncologists match cancer patients to personalized therapies. He is on the affiliate faculty at Institute for Systems Biology. He has more than two decades of oncology leadership spanning academic medicine, health-system administration, and health-tech innovation, including […]
Physician-Founder and CEO of Predicate AI Labs, focused on developing next-generation health intelligence technologies at the intersection of AI, physiological computing, digital health, medical devices, and edge computing. My expertise includes health technology strategy, product development, clinical innovation, commercialization, strategic partnerships, global health, and early-stage venture development. I advise organizations on emerging technologies, market opportunities, […]
Hyoung Lee is a CMC (Chemistry, Manufacturing, and Controls) strategist and chemical development leader with over 20 years of experience in the pharmaceutical industry. He currently leads HIL CMC Consulting LLC, providing strategic guidance on chemical development and CMC-related activities for drug development programs.nnHis expertise spans chemical process development, manufacturing strategy, and quality considerations throughout […]
David Scieszka is the Founder and CEO of Vertical Longevity Pharmaceuticals, a biotechnology company focused on longevity science and therapeutics. In this role, he leads the company’s strategic vision, research direction, and business development efforts in the emerging longevity biotech space. He completed his PhD in biomedical sciences at The University of New Mexico School […]
Extensive experience in drug development and approval. Worked at US FDA from 1991 to 2017 and then as SVP and Head Regulatory Affairs for Anavex Life Science, NY from 2017-2022. Currently working as a Regulatory Consultant to pharmaceutical companies.
Experienced matrix leader in product development, I support Pharma, Biotech, Medtech, Start-up and Investment Companies in optimizing the strategic and operational management of their asset portfolio to maximize patient access to innovative therapeutic solutions. I provide expertise in defining and executing candidate development strategies along with portfolio, program, project, and alliance management services through tailored […]
Ray Stevens is a biotech executive, company builder, and drug development operator with experience across CMC, IND strategy, translational development, clinical planning, commercialization, financing, and fundraising strategy. He helps early and mid stage life sciences companies convert complex science into credible, executable development plans. Ray works with teams to clarify the next highest value experiment, […]
I’ve spent 30 years in medtech and biotech—from the bench to the production floor to the C-suite—bringing more than 25 products to market across FDA 510(k), CE/MDR, and TGA pathways. I’ve seen exceptional science fail, not because the innovation wasn’t strong, but because the operational, regulatory, and governance foundations weren’t in place to support commercialization. […]
Healthcare executive and scientist with 25+ years of leadership in biotechnology, focused on turning scientific innovation into commercial and clinical impact. Proven track record advancing first-in-class therapies and diagnostics, securing FDA clearances, and driving growth across public and private companies—including generating $10M+ in oncology revenue, expanding diagnostic portfolios, and managing a $30M P&L. Currently Chief […]
I have over 30 years of experience in small molecule and biologic drug discovery and development across Europe and the USA, with extensive expertise in regulatory filings and project management within both biotech and large pharmaceutical companies. I believe in empowering teams to focus on their strengths without distraction, a leadership approach that has made […]